statements

Paushak Ltd.

BSE: 532742

Sector: Chemicals

Industry Group: Chemicals & Petrochemicals

Industry: Specialty Chemicals

621.05-36.9 (-5.62%)

23 Oct, 12:00 AM

Overview Analysis Statements

Technicals Forecast Peers Resources News

Income Statement

Abridged

Understanding Income Statement

Paushak Ltd. income statement covering revenue, operating profit, EBITDA, PAT and EPS across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	C 2012 Mar 31	2013 Mar 31	C 2014 Mar 31	C 2015 Mar 31	2016 Mar 31	R 2017 Mar 31	C 2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31	TTM Sep 30
	C 2012 Mar 31	2013 Mar 31	C 2014 Mar 31	C 2015 Mar 31	2016 Mar 31	R 2017 Mar 31	C 2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31	TTM Sep 30
Period length: Source:	12M AR	12M AR	12M AR	12M IR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M IR
Total Revenue	33.59	50.81	56.33	69.15	77.89	72.33	104.75	139.51	137.91	141.00	150.10	212.35	206.26	210.95	218.60	276.80
Cost of Operating Revenue	22.67	31.20	33.18	36.24	44.79	28.21	40.69	71.82	63.90	53.39	59.93	88.13	86.56	88.75	97.79	110.47
Gross Profit	10.93	19.62	23.15	32.91	33.11	44.11	64.06	67.69	74.00	87.61	90.17	124.21	119.70	122.20	120.81	166.33
Gross Margin	32.5	38.6	41.1	47.6	42.5	61.0	61.2	48.5	53.7	62.1	60.1	58.5	58.0	57.9	55.3	60.1
Total Operating Expenses	30.30	40.90	45.26	53.64	63.93	58.17	78.79	102.92	99.42	95.49	104.74	150.49	154.97	166.26	178.91	226.37
Operating Profit	3.29	9.92	11.06	15.51	13.96	14.16	25.96	36.59	38.48	45.51	45.36	61.85	51.29	44.69	39.69	50.43
Operating Margin	9.8	19.5	19.6	22.4	17.9	19.6	24.8	26.2	27.9	32.3	30.2	29.1	24.9	21.2	18.2	18.2
Financing Income/(Expense) - Net	-0.31	-0.19	-0.12	-0.04	-0.06	-0.06	-0.10	0.93	4.53	4.07	4.93	7.30	15.71	12.55	10.54	-3.73
Profit before Taxes	4.13	10.73	12.62	17.99	16.61	14.12	28.87	48.99	45.37	51.59	50.28	72.22	70.99	58.77	50.41	61.06
Income Taxes	0.68	2.94	3.80	4.99	4.19	3.18	7.39	10.03	10.46	14.29	12.67	18.22	16.64	9.40	11.09	13.77
Profit after Tax	3.45	7.79	8.82	12.99	12.42	10.94	21.47	38.96	34.91	37.30	37.61	54.01	54.35	49.38	39.33	47.29
PAT Margin	10.3	15.3	15.7	18.8	15.9	15.1	20.5	27.9	25.3	26.5	25.1	25.4	26.4	23.4	18.0	17.1
EPS - Basic - ex Extraordinary Items	1.34	3.04	3.44	5.07	4.84	4.26	8.37	15.71	14.16	15.13	15.25	21.90	22.04	20.03	15.95	19.18
EPS - Diluted - ex Extraordinary Items	1.34	3.04	3.44	5.07	4.84	4.26	8.37	15.71	14.16	15.13	15.25	21.90	22.04	20.03	15.95	19.18
EBIT	3.29	9.92	11.06	15.51	13.96	14.16	25.96	36.59	38.48	45.51	45.36	61.85	51.29	44.69	39.69	50.43
EBITDA	4.94	11.71	12.85	17.65	16.76	17.37	29.35	40.45	42.86	50.47	54.39	75.27	65.13	59.66	61.07	80.14
EBITDA Margin	14.7	23.1	22.8	25.5	21.5	24.0	28.0	29.0	31.1	35.8	36.2	35.4	31.6	28.3	27.9	29.0

Balance Sheet

Abridged

Understanding Balance Sheet

Paushak Ltd. balance sheet covering assets, liabilities, equity and borrowings across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2012 Mar 31	2013 Mar 31	C 2014 Mar 31	2015 Mar 31	R 2016 Mar 31	R 2017 Mar 31	2018 Mar 31	C 2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
	2012 Mar 31	2013 Mar 31	C 2014 Mar 31	2015 Mar 31	R 2016 Mar 31	R 2017 Mar 31	2018 Mar 31	C 2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
Source:	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR
Total Current Assets	16.00	24.05	31.89	38.25	39.81	26.25	55.90	89.86	110.52	94.90	103.50	147.25	215.53	99.58	131.66
Long-Term Investments	13.59	12.49	9.18	11.38	16.23	33.00	50.98	80.18	98.58	110.42	108.52	111.64	83.40	134.31	125.27
Property Plant & Equipment - Net	10.44	10.48	12.76	18.91	32.66	35.04	37.53	43.99	56.57	118.83	154.32	155.30	181.04	330.87	402.80
Total Non-Current Assets	24.04	22.97	21.94	30.29	48.89	68.04	88.51	124.21	159.30	233.87	263.02	267.49	265.82	472.40	528.28
Total Assets	41.48	47.02	53.83	68.54	88.70	94.28	144.42	214.06	269.83	328.76	366.52	414.74	481.35	571.98	659.94
Total Current Liabilities	8.71	7.73	7.01	9.38	9.88	7.11	22.24	14.80	16.22	27.18	27.01	22.32	25.97	44.44	65.44
Long Term Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	25.00	60.00
Total Non-Current Liabilities	1.48	1.33	1.14	1.76	4.51	4.15	9.05	21.69	26.36	29.92	33.95	38.73	47.26	62.05	103.37
Total Liabilities	10.18	9.06	8.15	11.14	14.39	11.26	31.29	36.50	42.59	57.10	60.96	61.05	73.22	106.49	168.82
Total Shareholders' Equity	31.30	37.97	45.67	57.39	74.31	83.02	113.13	177.57	227.24	271.66	305.56	353.69	408.12	465.49	491.12
Total Equity	31.30	37.97	45.67	57.39	74.31	83.02	113.13	177.57	227.24	271.66	305.56	353.69	408.12	465.49	491.12
Total Liabilities & Equity	41.48	47.02	53.83	68.54	88.70	94.28	144.42	214.06	269.83	328.76	366.52	414.74	481.35	571.98	659.94

Cash Flow

Abridged

Understanding Cash Flow Statement

Paushak Ltd. cash flow statement covering operating, investing and financing activities across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	C 2012 Mar 31	2013 Mar 31	R 2014 Mar 31	2015 Mar 31	2016 Mar 31	C 2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
	C 2012 Mar 31	2013 Mar 31	R 2014 Mar 31	2015 Mar 31	2016 Mar 31	C 2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
Period length: Source:	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR
Operating CF bef Changes in Working Cap	4.18	8.90	9.66	13.07	14.42	11.03	24.77	30.28	37.58	39.73	48.52	66.76	55.29	52.68	55.39
Working Capital - Increase/(Decrease)	-3.05	-6.54	-0.25	-4.37	0.52	2.08	-13.43	-6.13	6.96	-7.79	-1.28	-20.17	4.43	-10.98	-2.06
Net CF from Operating Activities	1.13	2.36	9.41	8.70	14.93	13.11	11.34	24.15	44.54	31.94	47.23	46.59	59.73	41.70	53.33
Capital Expenditures - Net	2.09	0.53	4.06	8.46	16.56	5.57	5.64	10.37	14.60	55.58	48.21	14.78	38.67	159.75	87.69
Net CF from Investing Activities	-1.06	0.08	-7.12	-7.79	-14.03	-11.51	-10.69	-0.72	-42.42	-30.72	-45.62	-42.35	-54.30	-61.27	-99.20
Dividends Paid - Cash - Total	0.60	0.60	0.90	0.90	0.91	0.95	0.94	0.92	1.52	1.84	1.85	3.66	5.33	6.05	6.05
Stock - Issuance/(Retirement) - Net	-	-	-	-	-	-	-	-21.25	-	-	-	-	-	-	-
Debt - LT & ST - Issuance/(Retirement) - Total	0.64	-1.68	-1.15	0.23	0.27	-0.48	0.54	-0.57	0.00	-	0.12	-0.12	-	25.01	51.93
Net Cash Flow from Financing Activities	-0.06	-2.38	-2.22	-0.83	-0.83	-1.62	-0.60	-22.93	-1.84	-1.84	-1.73	-3.79	-5.33	18.96	45.88
Free Cash Flow to Equity	-0.31	0.15	4.19	0.47	-1.36	7.06	6.24	13.20	29.94	-23.64	-0.85	31.70	21.05	-93.04	17.57
Free Operating CF net dividend	-1.55	1.03	4.44	-0.66	-2.54	6.60	4.76	12.85	25.96	-25.67	-2.87	25.79	15.31	-124.82	-40.81
Free Operating CF	-0.95	1.64	5.34	0.24	-1.63	7.54	5.70	13.77	27.49	-23.82	-1.02	29.45	20.64	-118.77	-34.76

Business Segment Analysis

FY End:

Mar 26

Paushak Ltd. business segment breakdown covering revenue, operating income and assets across key divisions for the selected financial year.

Capex

Speciality Chemicals (100.0%)₹ 88.09 Cr

Revenue / Sales

Speciality Chemicals (100.0%)₹ 218.60 Cr

Assets

Speciality Chemicals (100.0%)₹ 659.94 Cr

Operating Income

Speciality Chemicals (100.0%)₹ 39.69 Cr

Regional Segment Analysis

FY End:

Mar 26

Paushak Ltd. geographic revenue split showing domestic and international market performance across revenue and income for the selected financial year.

Revenue / Sales

India (82.7%)₹ 179.43 CrOutside india (17.3%)₹ 37.66 Cr

Historical Segment Analysis

Track how Paushak Ltd. segment contributions have evolved over multiple financial years to see which divisions are growing, shrinking or gaining strategic importance.

Capex

Sales

Assets

Operating Income

Business

Regional

Business

	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
Speciality Chemicals	17	56	48	17	39	160	88

Frequently Asked Questions

What is the revenue of Paushak Ltd.?

The latest trailing twelve month revenue of Paushak Ltd. is ₹ 276.80 Cr, reflecting a 1-year growth of 27.98% and a 3-year CAGR of 9.15%. Annual and quarterly revenue trends are available in the Income Statement section.

What is the net profit of Paushak Ltd.?

The latest trailing twelve month net profit (PAT) of Paushak Ltd. is ₹ 47.29 Cr, with a 3-year earnings CAGR of -3.02%. Detailed profit history across annual and quarterly periods is in the Income Statement section.

What is the EBITDA of Paushak Ltd.?

The trailing twelve month EBITDA of Paushak Ltd. is approximately ₹ 50.26 Cr (based on an operating margin of 18.16%). EBITDA reflects core operating profitability before interest, taxes, depreciation and amortisation.

What is the EPS of Paushak Ltd.?

The trailing twelve month Earnings Per Share (EPS) of Paushak Ltd. is 19.18. EPS trends across annual and quarterly periods are visible in the Income Statement section.

What is the debt level of Paushak Ltd.?

The debt-to-equity ratio of Paushak Ltd. stands at 0.13. The interest coverage ratio is 13.50x, reflecting the company's ability to service debt from operating earnings. The full breakdown of total borrowings is in the Balance Sheet section.

What is the book value per share of Paushak Ltd.?

The estimated book value per share of Paushak Ltd. is 209.51 (derived from a P/B ratio of 2.96 and market price of ₹ 621.05), reflecting the net asset value attributable to each share. See the Balance Sheet section for a full breakdown.

What is the cash flow from operations of Paushak Ltd.?

The trailing twelve month operating cash flow of Paushak Ltd. is ₹ 68.12 Cr. Annual and quarterly cash flow data is available in the Cash Flow section of the Statements tab.

Does Paushak Ltd. report consolidated or standalone financials?

Paushak Ltd. reports consolidated financials. You can toggle between consolidated and standalone views using the switch at the top of each statement section.